ABC Laboratories Subsidiary to Relocate to Missouri - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ABC Laboratories Subsidiary to Relocate to Missouri



ABC Laboratories, a contract analytical laboratory, plans to move operations of its subsidiary, Morse Laboratories based in Sacramento, California, to ABC's recently expanded campus in Columbia, Missouri. The move, scheduled to be completed by the end of October 2013, is aimed at integrating operations and building capacity.

The company has offered employees at the Sacramento location positions in Columbia and has named Kevin Clark, technical lead and director at Morse, the new senior director of operations for the Residue and Analytical Services Groups at ABC Laboratories. Clark has been with Morse for 28 years.

Effective October 15, all residue chemistry services will be provided under the ABC brand.

Source: ABC Laboratories

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
30%
Breakthrough designations
9%
Protecting the supply chain
39%
Expedited reviews of drug submissions
9%
More stakeholder involvement
13%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here